HIV drug resistance and viral fitness
- 1 January 2000
- book chapter
- Published by Elsevier
- Vol. 49, 41-66
- https://doi.org/10.1016/s1054-3589(00)49023-x
Abstract
No abstract availableKeywords
This publication has 89 references indexed in Scilit:
- Resistance to Human Immunodeficiency Virus Type 1 Protease InhibitorsAntimicrobial Agents and Chemotherapy, 1998
- Phenotypic Mechanism of HIV-1 Resistance to 3‘-Azido-3‘-deoxythymidine (AZT): Increased Polymerization Processivity and Enhanced Sensitivity to Pyrophosphate of the Mutant Viral Reverse TranscriptaseBiochemistry, 1998
- Limiting deoxynucleoside triphosphate concentrations emphasize the processivity defect of lamivudine-resistant variants of human immunodeficiency virus type 1 reverse transcriptaseAntimicrobial Agents and Chemotherapy, 1997
- The K65R Mutation Confers Increased DNA Polymerase Processivity to HIV-1 Reverse TranscriptasePublished by Elsevier ,1996
- Natural Variation in HIV-1 Protease, Gag p7 and p6, and Protease Cleavage Sites within Gag/Pol Polyproteins: Amino Acid Substitutions in the Absence of Protease Inhibitors in Mothers and Children Infected by Human Immunodeficiency Virus Type 1Virology, 1996
- Resistance of human immunodeficiency virus type 1 to protease inhibitors: selection of resistance mutations in the presence and absence of the drugJournal of General Virology, 1996
- Analysis of mutations at position 184 in reverse transcriptase of human immunodeficiency virus type 1Antimicrobial Agents and Chemotherapy, 1995
- High-level resistance to (-) enantiomeric 2'-deoxy-3'-thiacytidine in vitro is due to one amino acid substitution in the catalytic site of human immunodeficiency virus type 1 reverse transcriptaseAntimicrobial Agents and Chemotherapy, 1993
- Use of evolutionary limitations of HIV-1 multidrug resistance to optimize therapyNature, 1993
- Ordered Appearance of Zidovudine Resistance Mutations during Treatment of 18 Human Immunodeficiency Virus-Positive SubjectsThe Journal of Infectious Diseases, 1992